The disaster I never imagined having to worry about

AI Summary

The video details the unexpected and catastrophic failure of ritonavir, an HIV medication introduced in 1996, which transformed from a miracle drug into an unusable white paste by 1998. Initially, quality control issues led to the destruction of batches, but soon all production, both in Chicago and an alternative factory in Italy, yielded the same cloudy, non-dissolving capsules filled with needle-like crystals. Scientists discovered these crystals were a new, more stable polymorph of ritonavir (Form II) that was insoluble and could not be converted back to the original Form I. This phenomenon, known as a "disappearing polymorph," spreads like an infection, with tiny seed crystals becoming airborne and contaminating production lines and even personnel, effectively "seeding" new manufacturing sites. The video draws parallels to a 170-year-old debate between chemists Justus von Liebig and Friedrich Wöhler over isomers of silver fulminate and silver cyanate, demonstrating how identical chemical compositions can have vastly different properties due to atomic arrangement. It also uses the tempering of chocolate to illustrate polymorphism, where cocoa butter can form six different crystal structures with varying melting points and textures. The "tin pest" phenomenon, where silvery tin transforms into crumbly gray tin at low temperatures, further explains how a stable polymorph can act as a nucleation site, lowering the energy barrier for transformation and spreading rapidly. Abbott eventually abandoned Form I ritonavir, reverting to an older liquid formulation, as Form II proved impossible to eliminate. The presenter emphasizes the unpredictability of polymorphism, noting that over half of all compounds are polymorphic, and while rare, such events can devastate drug supplies, highlighting the critical need for pharmaceutical companies to invest heavily in polymorph screening.

Claims Extracted (14)